Menu
GWAS Study

Genetic investigation of fibromuscular dysplasia identifies risk loci and shared genetics with common cardiovascular diseases.

Georges A, Yang ML, Berrandou TE et al.

34654805 PubMed ID
GWAS Study Type
8656 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

GA
Georges A
YM
Yang ML
BT
Berrandou TE
BM
Bakker MK
DO
Dikilitas O
KS
Kiando SR
ML
Ma L
SB
Satterfield BA
SS
Sengupta S
YM
Yu M
DJ
Deleuze JF
DD
Dupré D
HK
Hunker KL
KS
Kyryachenko S
LL
Liu L
SI
Sayoud-Sadeg I
AL
Amar L
BC
Brummett CM
CD
Coleman DM
DV
d'Escamard V
DL
de Leeuw P
FN
Fendrikova-Mahlay N
KD
Kadian-Dodov D
LJ
Li JZ
LA
Lorthioir A
PM
Pappaccogli M
PA
Prejbisz A
SW
Smigielski W
SJ
Stanley JC
ZM
Zawistowski M
ZX
Zhou X
ZS
Zöllner S
AP
Amouyel P
DB
De Buyzere ML
DS
Debette S
DP
Dobrowolski P
DW
Drygas W
GH
Gornik HL
OJ
Olin JW
PJ
Piwonski J
RE
Rietzschel ER
RY
Ruigrok YM
VM
Vikkula M
WC
Warchol Celinska E
JA
Januszewicz A
KI
Kullo IJ
AM
Azizi M
JX
Jeunemaitre X
PA
Persu A
KJ
Kovacic JC
GS
Ganesh SK
BN
Bouatia-Naji N
Chapter II

Abstract

Summary of the research findings

Fibromuscular dysplasia (FMD) is an arteriopathy associated with hypertension, stroke and myocardial infarction, affecting mostly women. We report results from the first genome-wide association meta-analysis of six studies including 1556 FMD cases and 7100 controls. We find an estimate of SNP-based heritability compatible with FMD having a polygenic basis, and report four robustly associated loci (PHACTR1, LRP1, ATP2B1, and LIMA1). Transcriptome-wide association analysis in arteries identifies one additional locus (SLC24A3). We characterize open chromatin in arterial primary cells and find that FMD associated variants are located in arterial-specific regulatory elements. Target genes are broadly involved in mechanisms related to actin cytoskeleton and intracellular calcium homeostasis, central to vascular contraction. We find significant genetic overlap between FMD and more common cardiovascular diseases and traits including blood pressure, migraine, intracranial aneurysm, and coronary artery disease.

1,556 European ancestry cases, 7,100 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

8656
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
U.S., Belgium, Poland, France
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.